SCHEMBL6165367

SCHEMBL6165367

CC1(C)CCc2c(c(-c3ccco3)nn2CC(F)(F)F)C1=O

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EEF2K O00418 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
HSF1 Q00613 1/20 0.31
ALDH1A1 P00352 3/20 0.31
KDM4E B2RXH2 2/20 0.31
HPGD P15428 2/20 0.31
HSD17B10 Q99714 2/20 0.31
ADORA2A P29274 2/20 0.31
CFTR P13569 1/20 0.30
MERTK Q12866 1/20 0.30
POLQ O75417 2/20 0.30
POLB P06746 2/20 0.30
MEN1 O00255 1/20 0.30
USP2 O75604 1/20 0.30
LMNA P02545 1/20 0.30
MAPT P10636 1/20 0.30
THRB P10828 1/20 0.30
PKM P14618 1/20 0.30
ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164523 0.84
SCHEMBL6164754 0.83 EEF2K (0.34) EEF2KTDP1L3MBTL1HSF1ALDH1A1
SCHEMBL6163503 0.82 PTGS2 (0.40) ALDH1A1HSD17B10POLQMEN1ALOX15
SCHEMBL6163459 0.80 HDAC9 (0.35) ALDH1A1KDM4EMERTKPOLQKMT2A
SCHEMBL6164936 0.79 CDC7 (0.39) ALDH1A1
SCHEMBL6165976 0.79 ADORA1 (0.38) L3MBTL1HSF1ALDH1A1KDM4EHPGD
SCHEMBL6166715 0.78 KCNK3 (0.39) HSD17B10ADORA2ALMNAKMT2A
SCHEMBL6167206 0.77 METAP2 (0.34) POLQ
SCHEMBL6167776 0.76 AURKA (0.31) KDM4EMAPT
SCHEMBL6166778 0.74 TSHR (0.34) L3MBTL1HPGDPOLQLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed